These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29069995)

  • 1. PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C.
    Hansen JF; Juul Nielsen M; Nyström K; Leeming DJ; Lagging M; Norkrans G; Brehm Christensen P; Karsdal M
    Scand J Gastroenterol; 2018 Jan; 53(1):83-87. PubMed ID: 29069995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C.
    Nielsen MJ; Veidal SS; Karsdal MA; Ørsnes-Leeming DJ; Vainer B; Gardner SD; Hamatake R; Goodman ZD; Schuppan D; Patel K
    Liver Int; 2015 Feb; 35(2):429-37. PubMed ID: 25308921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.
    Cordie A; Salama A; El-Sharkawy M; El-Nahaas SM; Khairy M; Elsharkawy A; Hassany M; Esmat G
    J Med Virol; 2018 Jun; 90(6):1106-1111. PubMed ID: 29476628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population.
    Nielsen MJ; Leeming DJ; Goodman Z; Friedman S; Frederiksen P; Rasmussen DGK; Vig P; Seyedkazemi S; Fischer L; Torstenson R; Karsdal MA; Lefebvre E; Sanyal AJ; Ratziu V
    J Hepatol; 2021 Dec; 75(6):1292-1300. PubMed ID: 34454994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients.
    Attallah AM; El-Far M; Abdel Malak CA; Omran MM; Farid K; Hussien MA; Albannan MS; Attallah AA; Elbendary MS; Elbesh DA; Elmenier NA; Abdallah MO
    Ann Hepatol; 2015; 14(2):225-33. PubMed ID: 25671832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores: How Much Do Routine Blood Tests Tell About Liver Fibrosis in Chronic Hepatitis C?
    Thandassery RB; Al Kaabi S; Soofi ME; Mohiuddin SA; John AK; Al Mohannadi M; Al Ejji K; Yakoob R; Derbala MF; Wani H; Sharma M; Al Dweik N; Butt MT; Kamel YM; Sultan K; Pasic F; Singh R
    J Clin Gastroenterol; 2016 Jul; 50(6):518-23. PubMed ID: 26974762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.
    Maieron A; Salzl P; Peck-Radosavljevic M; Trauner M; Hametner S; Schöfl R; Ferenci P; Ferlitsch M
    Aliment Pharmacol Ther; 2014 Feb; 39(3):331-8. PubMed ID: 24308724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
    El-Mezayen HA; Habib S; Marzok HF; Saad MH
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):378-85. PubMed ID: 25874509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
    Zachou K; Gabeta S; Shums Z; Gatselis NK; Koukoulis GK; Norman GL; Dalekos GN
    Eur J Intern Med; 2017 Mar; 38():83-88. PubMed ID: 28100410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple approaches to assess fourteen non-invasive serum indexes for the diagnosis of liver fibrosis in chronic hepatitis C patients.
    Andrés-Otero MJ; De-Blas-Giral I; Puente-Lanzarote JJ; Serrano-Aulló T; Morandeira MJ; Lorente S; Lou-Bonafonte JM
    Clin Biochem; 2016 May; 49(7-8):560-5. PubMed ID: 26968102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
    Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
    Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
    Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
    J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes.
    Bril F; Leeming DJ; Karsdal MA; Kalavalapalli S; Barb D; Lai J; Rabe M; Cusi K
    Diabetes Care; 2019 Jul; 42(7):1348-1351. PubMed ID: 31221701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C.
    Hernández-Bartolomé Á; López-Rodríguez R; Borque MJ; González-Moreno L; Real-Martínez Y; García-Buey L; Moreno-Otero R; Sanz-Cameno P
    World J Gastroenterol; 2016 Nov; 22(44):9744-9751. PubMed ID: 27956798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
    Kim WR; Berg T; Asselah T; Flisiak R; Fung S; Gordon SC; Janssen HL; Lampertico P; Lau D; Bornstein JD; Schall RE; Dinh P; Yee LJ; Martins EB; Lim SG; Loomba R; Petersen J; Buti M; Marcellin P
    J Hepatol; 2016 Apr; 64(4):773-80. PubMed ID: 26626497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.